Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Clinical trial NCT01396421 · COMPLETED
Trial details
- NCT number
- NCT01396421
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-01-01
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.